Last reviewed · How we verify

NCT02985515: SNIFFED

Steroid Nasal Irrigation for Flavor Evaluation and Detection Study

Completed NA Results posted Last updated 4 November 2022
What this trial tests

NA trial testing Smell training in Olfactory Disorder in 51 participants. Completed in 20 November 2019.

Timeline
28 September 2016
Primary endpoint
20 November 2019
20 November 2019

Quick facts

Lead sponsorWashington University School of Medicine
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment51
Start date28 September 2016
Primary completion20 November 2019
Estimated completion20 November 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Washington University School of Medicine

Who can join

Adults 18 to 70, any sex, with Olfactory Disorder. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Pre- and Post-intervention Difference in Functional Connectivity Before and After Smell Training. Primary · 12 weeks

Baseline and post-intervention connectivity within and between regions of interest in the olfactory and olfactory related networks using resting state fMRI will be obtained. Resting-state connectivity was analyzed using the CONN toolbox version 18b (https://web.conn-toolbox.org/) and SPM12, version 7487 (Wellcome Trust Centre for Neuroimaging). Functional connectivity values (Fisher z-transformed Pearson correlation coefficients) were compared using a paired, 2-tailed t test and corrected for multiple comparisons. p\<0.05 was considered to be significant.

GroupValue95% CI
Smell Training5
Pre- and Post-intervention Difference in Smell Testing Before and After Budesonide Treatment Secondary · 30 days

Objective pre- and post-intervention differences of participant performance on the UPSIT and Sniffin Sticks tests before and after budesonide saline nasal irrigation. University of Pennsylvania Identification Test (UPSIT) consists of 4 odor-impregnated booklets that participants scratch and sniff to identify various odors, and scores account for differences in sex. Hyposmia is defined as a score of 19 to 34 for females and 19 to 33 for males. Anosmia for either sex is defined as a score below 18. Possible scores range from 0 to 40 with higher scores indicating better sense of smell. Sniffin'

UPSIT
GroupValue95% CI
Budesonide Nasal Irrigation19.55 – 40
TDI
GroupValue95% CI
Budesonide Nasal Irrigation17.57 – 27.2
Subjective Response to Smell Training Intervention Secondary · 12 weeks

Participants subjective sense of smell following intervention is measured using a visual analogue scale from 0 to 100 with 0 representing no sense of smell and 100 representing best possible sense of smell.

GroupValue95% CI
Smell Training23.89 – 83.8
Comparison of Olfactory Network in Healthy Controls to Study Participants Secondary · 1 week

Baseline functional connectivity within and between the olfactory and associated networks of healthy controls will be compared to that of study participants prior to smell intervention treatment as measured by rs-fMRI.Resting-state connectivity was analyzed using the CONN toolbox version 18b (https://web.conn-toolbox.org/) and SPM12, version 7487 (Wellcome Trust Centre for Neuroimaging). Functional connectivity values (Fisher z-transformed Pearson correlation coefficients) were compared using a paired, 2-tailed t test and corrected for multiple comparisons . P \< .05 was considered statistical

GroupValue95% CI
Control Group13
Pre- and Post-intervention Difference in Smell Testing Before and After Smell Training Secondary · 12 weeks

Objective pre- and post-intervention differences of participant performance on the UPSIT and Sniffin Sticks tests before and after budesonide saline nasal irrigation. University of Pennsylvania Identification Test (UPSIT) consists of 4 odor-impregnated booklets that participants scratch and sniff to identify various odors, and scores account for differences in sex. Hyposmia is defined as a score of 19 to 34 for females and 19 to 33 for males. Anosmia for either sex is defined as a score below 18. Possible scores range from 0 to 40 with higher scores representing better sense of smell. Sniffi

UPSIT
GroupValue95% CI
Smell Training199 – 40
TDI
GroupValue95% CI
Smell Training18.37 – 34.5
Pre and Post Difference in QOD-NS After Smell Training Secondary · 12 weeks

The QOD-NS is a validated 17-item questionnaire that pertains to olfactory-specific quality of life domains adversely impacted by olfactory dysfunction and is inversely scored (maximum score of 51), with higher scores reflective of more impaired quality of life.

GroupValue95% CI
Smell Training7.40 – 17.1

Adverse events — posted to ClinicalTrials.gov

Time frame: Up through 13 months. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Control Group
Serious: 0/20 (0%)
Deaths: 0/20
Budesonide Nasal Irrigation
Serious: 0/31 (0%)
Deaths: 0/31
Other adverse events (3 terms — click to expand)

ReactionSystemControl GroupBudesonide Nasal Irrigation
CavernomaNervous system disorders
extra-axial meningiomasNervous system disorders
pleomorphic adenomaNervous system disorders

Data from ClinicalTrials.gov NCT02985515 adverse events section.

Sponsor's own description

The purpose of this research study is to examine the efficacy of a 12-week smell training intervention for participants with olfactory dysfunction following an infection of the upper respiratory tract.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Olfactory Disorder

Currently open trials in the same condition.

Other Washington University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02985515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing